Quest Diagnostics Inc. DGX
Analyst Ratings
- Consensus
- Hold — 4 Buy · 7 Hold · 0 Sell (11 analysts)
- Avg. Price Target
- $233.18 (-5.4% downside)
Key Stats
- Today's Range
- $244.89 – $247.63
- 50-Day Range
- $201.00 – $248.69
- 52-Week Range
- $171.18 – $248.69
- Volume
- 1.92 million shs
- Average Volume
- 917K shs
- Market Cap
- $27.31 billion
- P/E Ratio
- 26.16
- Dividend Yield
- 1.40%
Valuation
- P/E Ratio
- 26.16
- Price / Book
- 3.49
- Price / Sales
- 2.36
Dividend
- Dividend Yield
- 1.40%
- Annual Dividend
- $3.44
- Payout Ratio
- 36.52%
- Ex-Dividend Date
- 2026-10-06
Short Interest
- Short Interest
- 4.76%
- Days to Cover
- 6.87
Financials (TTM)
- Revenue
- $11.56 billion
- Net Income
- $1.11 billion
- Net Margin
- 9.63%
- Return on Equity
- 14.23%
- Debt-to-Equity
- 0.72
About Quest Diagnostics Inc.
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 97% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,400 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.
Related Stocks
Compare head-to-head: DGX vs NTRA·DGX vs CAI·DGX vs BLLN·DGX vs CDNA
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.